The S128N mutation combined with an additional potential <i>N</i> -linked glycosylation site at residue 133 in hemagglutinin affects the antigenicity of the human H7N9 virus
Wanli Liu(Center for Life Sciences), Yuelong Shu(Sun Yat-sen University), Xinlan Li(National Health and Family Planning Commission), Xin Ma(Kunming Medical University), Tian Bai(Chinese Academy of Medical Sciences & Peking Union Medical College), Jinlei Guo(North West Agriculture and Forestry University), Jianfang Zhou(National Institute for Viral Disease Control and Prevention), Xiaojun Wang(Chinese Academy of Agricultural Sciences), Lei Yang(Taiwan Centers for Disease Control), Junfeng Guo(Taiwan Centers for Disease Control), Dayan Wang(Sun Yat-sen University), Xiyan Li(Fujian Medical University), Hongbin Liu(Xinjiang Uygur Autonomous Region Disease Prevention and Control Center)
Cited by 5
Related Papers
A Novel Coronavirus from Patients with Pneumonia in China, 2019
|New England Journal of Medicine|2020|30.5k
Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding
|The Lancet|2020|12.6k
Human Infection with a Novel Avian-Origin Influenza A (H7N9) Virus
|New England Journal of Medicine|2013|2.4k
Epidemiology of Human Infections with Avian Influenza A(H7N9) Virus in China
|New England Journal of Medicine|2013|698